To make an appointment, please call 1-800-KARMANOS (1-800-527-6266) or request an appointment online
As a leader in cancer research, Karmanos is able to offer patients access to innovative treatments and clinical trials that are often times not available anywhere else.
To offer hope and longer life to patients with all types of cancer, Karmanos offers the latest types of therapy through our clinical trials program. Through clinical trials, we are creating new knowledge about how therapies fight cancer and provide national leadership in testing these new therapies.
We understand that cancer is a complex disease that demands complex care. We provide each patient with a dynamic, carefully constructed treatment plan focused on their specific cancer and their unique needs.
We listen to you to design a plan that provides you with respect, compassionate care and is responsive to your emotional and practical concerns.
Parts 1, 2, 3 and 4
Patients must meet all the following criteria to be eligible to participate in the study:
Part 2
Patients must meet the following modified criterion to enter Part 2 of the study:
Part 3
Patients must meet the following additional and/or modified inclusion criteria to enter Part 3 of the study:
Part 4
Patients must meet the following additional and/or modified inclusion criteria to enter Part 4 of the study:
Patients who meet any one of the following criteria at baseline will be excluded from study participation:
o Concomitant with alkaline phosphatase > 2.5 times ULN (for Parts 3 and 4).
Part 2 For Part 2, there is no specific additional or modified exclusion criteria. Parts 3 & 4
For Parts 3 & 4, patients who meet any one of the following additional exclusion criteria at baseline will be excluded from study participation: